Further confirmation of Treg function was obtained via suppression of autologous polyclonal CD4+ Teff proliferation in response to CD3/CD28 stimulation, with findings consistent across both healthy control and T1D donors (Figure 2C). Here, CD28 is linked to type 1 diabetes mellitus.